 Chanelle Pharmaceuticals Manufacturing Ltd has just launched a new Meloxicam Chewable tablet for dogs, under their trademark Rheumocam. This product helps alleviate inflammation and pain in both acute and chronic musculo-skeletal disorders in dogs.
Rheumocam chewable tablets are available in strengths of 1 mg and 2.5 mg. They are pork flavoured and chewable, to aid administration. The addition of the Meloxicam tablets extends Chanelle's current companion animal NSAID's range of Carprofen tablets (Canidryl) and Meloxicam liquid (Rheumocam Oral Suspension) for dogs.
"The addition of Rheumocam tablets brings us another step closer to a full range of generic NSAID's for dogs." Michael Burke, MRCVS, Managing Director.
Rheumocam Chewable Tablets for dogs are firstly being launched throughout Ireland and the UK and will be launched across Europe over the next few months.
***** Press Release Ends *****
For Further Press Release/Company/Product Details Please Contact:
Sarah Noone,
Marketing Executive,
Chanelle Group,
Loughrea,
Co Galway, Ireland.
Phone: 00 353 (0) 91 870147
Email:snoone@chanellegroup.ie
Return To News |
